Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV256
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,241
Award facts
- Contract value 100% obligated
- $15,240.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,240.88 to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 6, 2026, for the supply of Cosentyx (secukinumab) Unready 300 mg pen 2ml injections. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of January 7, 2026, and performance will occur at the awardee's facility in Conshohocken, Pennsylvania. The order is issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide.
Amerisourcebergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's federal contracting portfolio demonstrates extensive experience delivering a diverse range of pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. This delivery order for Cosentyx, a specialty immunosuppressant medication, reflects the company's ongoing capability to fulfill government requirements for high-value pharmaceutical commodities through competitive, firm fixed-price arrangements.
Quick answers
Who was awarded contract SPE2DR26FV256?
SPE2DR26FV256 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FV256 worth?
The government has obligated $15,241 on SPE2DR26FV256.
Is contract SPE2DR26FV256 an order under another contract?
Yes. SPE2DR26FV256 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV256 competed?
The extent of competition for SPE2DR26FV256 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award